Review

Osteoporosis in Adults with Intellectual Disabilities

Authors: Louis R. Petrone, MD

Abstract

The medical care of adults with intellectual disabilities (ID) originates in primary care physicians’ offices. With the move toward the deinstitutionalization of these individuals in the 1970s and 1980s and the increasing longevity of this population, more adults with disabilities are living in the community. Primary care providers need to be comfortable with treating the conditions of these individuals with special needs. Individuals with ID are at higher than average risk for many chronic conditions. One condition that is often overlooked or underdiagnosed is osteoporosis. Much research regarding osteoporosis has been conducted in postmenopausal women and other high-risk groups; however, gaps remain in our understanding of the evaluation and treatment of osteoporosis in adults with ID.

This content is limited to qualifying members.

Existing members, please login first.

If you have an existing account please login now to access this article or view your purchase options.

Purchase only this article ($15)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. American Association of Intellectual and Developmental Disabilities. Available at: http//www.aamr.org/content_181.cfm?navID=12. Accessed November 3, 2010.
 
2. WHO Scientific Group on the Assessment of Osteoporosis at Primary Care Level. Summary Meeting Report, Brussels, Belgium, May 5–7, 2004. World Health Organization 2011. Cited April 15, 2011.
 
3. Fact Sheet: The World Health Report 2001. World Health Organization 2011. Cited April 15, 2011.
 
4. Leslie WD, Pahlavan PS, Roe EB, et al. Bone density and fragility fractures in patients with developmental disabilities. Osteoporos Int 2009; 20: 379–383.
 
5. Smeltzer SC, Zimmerman V, Capriotti T. Osteoporosis risk and low bone mineral density in women with physical disabilities. Arch Phys Med Rehabil 2005; 86: 582–586.
 
6. Center J, Beange H, McElduff A. People with mental retardation have an increased prevalence of osteoporosis: a population study. Am J Ment Retard 1998; 103: 19–28.
 
7. Jaffe JS, Timell AM, Elolia R, et al. Risk factors for low bone mineral density in individuals residing in a facility for the people with intellectual disability. J Intellect Disabil Res 2005; 49 (pt 6): 457–462.
 
8. Srikanth R, Cassidy G, Joiner C, et al. Osteoporosis in people with intellectual disabilities: a review and a brief study of risk factors for osteoporosis in a community sample of people with intellectual disabilities. J Intellect Disabil Res 2011; 55: 53–62.
 
9. Jaffe JS, Timell AM. Prevalence of low bone density in institutionalized men with developmental disabilities. J Clin Densitom 2003; 6: 143–147.
 
10. Nakano H, Aoyagi K, Ohgi S, et al. Factors influencing metacarpal bone mineral density in adults with cerebral palsy. J Bone Miner Metab 2003; 21: 409–414.
 
11. Schrager S. Osteoporosis in women with disabilities. J Womens Health (Larchmt) 2004; 13: 431–437.
 
12. Takata S, Yasui N. Disuse osteoporosis. J Med Invest 2001; 48: 147–156.
 
13. Henderson RC, Lin PP, Greene WB. Bone-mineral density in children and adolescents who have spastic cerebral palsy. J Bone Joint Surg Am 1995; 77: 1671–1681.
 
14. Wagemans AM, Fiolet JF, van der Linden ES, et al. Osteoporosis and intellectual disability: is there any relation? J Intellect Disabil Res 1998; 42 (pt 5): 370–374.
 
15. Vanlint S, Nugent M. Vitamin D and fractures in people with intellectual disability. J Intellect Disabil Res 2006; 50 (pt 10): 761–767.
 
16. Hawli Y, Nasrallah M, El-Hajj FG. Endocrine and musculoskeletal abnormalities in patients with Down syndrome. Nat Rev Endocrinol 2009; 5: 327–334.
 
17. Ray JG, Papaioannou A, Ioannidis G, et al. Anticonvulsant drug use and low bone mass in adults with neurodevelopmental disorders. QJM 2002; 95: 219–223.
 
18. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266–281.
 
19. Babayigit A, Dirik E, Bober E, et al. Adverse effects of antiepileptic drugs on bone mineral density. Pediatr Neurol 2006; 35: 177–181.
 
20. Mikati MA, Dib L, Yamout B, et al. Two randomized vitamin D trials in ambulatory patients on anticonvulsants: impact on bone. Neurology 2006; 67: 2005–2014.
 
21. Ryder KM, Williams J, Womack C, et al. Appendicular fractures: a significant problem among institutionalized adults with developmental disabilities. Am J Ment Retard 2003; 108: 340–346.
 
22. Glick NR, Fischer MH, Heisey DM, et al. Epidemiology of fractures in people with severe and profound developmental disabilities. Osteoporos Int 2005; 16: 389–396.
 
23. Lohiya GS, Crinella FM, Tan-Figueroa L, et al. Fracture epidemiology and control in a developmental center. West J Med 1999; 170: 203–209.
 
24. Henderson RC, Lark RK, Gurka MJ, et al. Bone density and metabolism in children and adolescents with moderate to severe cerebral palsy. Pediatrics 2002; 110 (1 pt 1): e5.
 
25. Hale L, Bray A, Littmann A. Assessing the balance capabilities of people with profound intellectual disabilities who have experienced a fall. J Intellect Disabil Res 2007; 51 (pt 4): 260–268.
 
26. Bruckner J, Herge E. Assessing the risk of falls in elders with mental retardation and developmental disabilities. Top Geriatr Rehabil 2003; 19: 206–211.
 
27. Cox CR, Clemson L, Stancliffe RJ, et al. Incidence of and risk factors for falls among adults with an intellectual disability. J Intellect Disabil Res 2010; 54: 1045–1057.
 
28. Hsieh K, Heller T, Miller AB. Risk factors for injuries and falls among adults with developmental disabilities. J Intellect Disabil Res 2001; 45 (pt 1): 76–82.
 
29. Finlayson J, Morrison J, Jackson A, et al. Injuries, falls and accidents among adults with intellectual disabilities. Prospective cohort study. J Intellect Disabil Res 2010; 54: 966–980.
 
30. International Society of Clinical Densitometry 2011. Cited April 15, 2011. Available at: http://www.iscd.org/Visitors/positions/OfficialPositionsText.cfm.
 
31. Lohiya GS, Tan-Figueroa L, Iannucci A. Identification of low bone mass in a developmental center: finger bone mineral density measurement in 562 residents. J Am Med Dir Assoc 2004; 5: 371–376.
 
32. Guijarro M, Valero C, Paule B, et al. Bone mass in young adults with Down syndrome. J Intellect Disabil Res 2008; 52 (pt 3): 182–189.
 
33. Wilkinson JE, Culpepper L, Cerreto M. Screening tests for adults with intellectual disabilities. J Am Board Fam Med 2007; 20: 399–407.
 
34. Sholas MG, Tann B, Gaebler-Spira D. Oral bisphosphonates to treat disuse osteopenia in children with disabilities: a case series. J Pediatr Orthop 2005; 25: 326–331.
 
35. Iwasaki T, Takei K, Nakamura S, et al. Secondary osteoporosis in long-term bedridden patients with cerebral palsy. Pediatr Int 2008; 50: 269–275.
 
36. Pearson EG, Nance PW, Leslie WD, et al. Cyclical etidronate: its effect on bone density in patients with acute spinal cord injury. Arch Phys Med Rehabil 1997; 78: 269–272.
 
37. Sato Y, Asoh T, Kaji M, et al. Beneficial effect of intermittent cyclical etidronate therapy in hemiplegic patients following an acute stroke. J Bone Miner Res 2000; 15: 2487–2494.
 
38. Shane E, Burr D, Ebeling PR, et al. Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 2010; 25: 2267–2294.
 
39. Pazianas M, Miller P, Blumentals WA, et al. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics. Clin Ther 2007; 29: 1548–1558.
 
40. Sheridan KJ. Osteoporosis in adults with cerebral palsy. Dev Med Child Neurol 2009; 51 (suppl 4): 38–51.
 
41. Sherrard J, Ozanne-Smith J, Staines C. Prevention of unintentional injury to people with intellectual disability: a review of the evidence. J Intellect Disabil Res 2004; 48 (pt 7): 639–645.
 
42. Vanlint S, Nugent M, Durvasula S. Vitamin D and people with intellectual disability. Aust Fam Physician 2008; 37: 348–351.
 
43. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, et al. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ 2009; 339: b3692.
 
44. Kilpinen-Loisa P, Arvio M, Ilvesmaki V, et al. Vitamin D status and optimal supplementation in institutionalized adults with intellectual disability. J Intellect Disabil Res 2009; 53: 1014–1023.
 
45. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, et al. Effect of vitamin D on falls: a meta-analysis. JAMA 2004; 291: 1999–2006.
 
46. Lee JJ, Lyne ED. Pathologic fractures in severely handicapped children and young adults. J Pediatr Orthop 1990; 10: 497–500.
 
47. Bolland MJ, Grey A, Avenell A, et al. Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women’s Health Initiative limited access dataset and meta-analysis. BMJ 2011; 342: d2040.
 
48. Elsheikh M, Dunger DB, Conway GS, et al. Turner’s syndrome in adulthood. Endocr Rev 2002; 23: 120–140.
 
49. Chad KE, Bailey DA, McKay HA, et al. The effect of a weight-bearing physical activity program on bone mineral content and estimated volumetric density in children with spastic cerebral palsy. J Pediatr 1999; 135: 115–117.
 
50. Goemaere S, Van LM, De NP, et al. Bone mineral status in paraplegic patients who do or do not perform standing. Osteoporos Int 1994; 4: 138–143.
 
51. Barnhart RC, Connolly B. Aging and Down syndrome: implications for physical therapy. Phys Ther 2007; 87: 1399–1406.